In 2025, the gold standard of ADHD diagnosis and treatment is evolving, shaped by updated DSM-5 criteria, new…
Blog
CHIRP model’s objective technology (QbCheck) improves ADHD care efficiency in New Zealand (2023)
QbCheck’s objective ADHD testing solutions land in New Zealand. The CHIRP model (combining paediatrics, child development services and…
ADHD vs Autism in clinic settings: red flags and co-diagnosis tips
More than half of adults with ADHD also live with another mental health condition, and almost 40%…
How objective ADHD technology is reducing uncertainty and creating efficiency
ADHD is one of the most prevalent neurodevelopmental disorders, but access to timely and efficient treatment continues to…
What is the future of ADHD care? Recap of the 2025 ADHD Expert Consortium meeting
Each year, the ADHD Expert Consortium meets to review progress and identify new strategies to address gaps in…
Helping teachers understand ADHD: A resource toolkit for schools
Supporting students with ADHD is one of the most common yet complex challenges teachers face in today’s classrooms….
Can objective testing improve ADHD patient outcomes?
The US healthcare system is shifting away from volume-driven visits and tests, and toward value-based care, also…
Why patient developmental history is crucial for an ADHD diagnosis: Key insights from our webinar
ADHD is a neurodevelopmental disorder, meaning symptoms must have been present since childhood (APA, DSM-5). Understanding a patient’s…
How to differentiate an ADHD and an ASD diagnosis: Expert clinician webinar
In this webinar, ADHD experts Jess Brunet and Ryan Martin delve into the complexities of differentiating between ADHD…
Navigating prescribing restrictions for ADHD medication: Strategies for US clinics
In the US, strict and ever-changing prescribing rules, medication shortages, and increased scrutiny on controlled substances prescribed…
